OpGen US Ares Sequencing Services
Aug 25, 2022
OpGen has commercially launched antimicrobial resistance (AMR)-related next-generation sequencing services developed by its subsidiary Ares within the US. These services include ARESiss, a whole-genome sequencing workflow for bacterial isolates, the AMR database ARESdb, the ARESid bacterial identification workflow, and the ARESupa AMR marker capture assay. Reports from the sequencing service are available through the subscription-based web application AREScloud.